Charles Boothe joins AllazoHealth as Vice President, Sales and Business Development. - NEWS10 ABC: Albany, New York News, Weather, Sports

Charles Boothe joins AllazoHealth as Vice President, Sales and Business Development.

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE AllazoHealth

NEW YORK, May 8, 2014 /PRNewswire/ -- Charles Boothe recently joined AllazoHealth as Vice President, Sales and Business Development.

Mr. Boothe has more than 25 years of marketing leadership and sales management experience in healthcare IT and pharmaceuticals.  Between 2008 and 2011, he served as Vice President of Payer and Provider Services at Epocrates and developed sales efforts with 130 health plans for Epocrates Formulary Hosting Services in mobile devices.  In 2011, Mr. Boothe took his technology expertise into the e-prescribing space at Dr. First, Inc., where he led strategic development of technology solutions for increasing connectivity and interoperability for health plans, hospitals and physicians. He has also served on a number of e-health collaborative committees such as the New York e-Health Collaborative and NCPDP Prescription Drug Abuse Solutions Committee.

"Charles's strong relationships with PBMs and payers will accelerate our growth as we continue to roll-out AllazoEngine's solutions across the market." said Clifford Jones, CEO of AllazoHealth.

"I am pleased to bring my sales leadership experience to this innovative and much-needed predictive analytics venture," said Charles Boothe. "I am passionate about driving advancement in healthcare and am excited to be a part of AllazoHealth's energetic and experienced team."

About AllazoHealth:

AllazoHealth is an analytics firm that is solving the problem of medication non-adherence in the United States, which results in as much as $290 billion in avoidable costs annually.  AllazoHealth's proprietary AllazoEngine™ combines cutting-edge behavioral science research, industry expertise, and advanced predictive analytics to both anticipate medication non-adherence and forecast the most effective intervention strategy for each individual patient.  Health insurers, pharmacy benefit management companies, and accountable care organizations benefit significantly from Allazo's technology.  When patients take their medications as prescribed, patient health improves and more expensive care is avoided, decreasing overall health care costs.  In addition, improved medication adherence increases HEDIS scores and Medicare star ratings.  More information about AllazoHealth can be found at http://www.allazohealth.com.

CONTACT: Charles Boothe, (888) 464-2776 ext. 707, charles.boothe@allazohealth.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

341 Northern Blvd., Albany, NY 12204

Telephone: 518.436.4822
Fax: 518.426.4792
Email: news@news10.com

Can’t find something?
Powered by WorldNow
All content © Copyright 2000 - 2014 Young Broadcasting of Albany, Inc. A Media General Company.